Emily Robitschek

1.3k total citations
3 papers, 2 citations indexed

About

Emily Robitschek is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Emily Robitschek has authored 3 papers receiving a total of 2 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Oncology, 2 papers in Cancer Research and 1 paper in Molecular Biology. Recurrent topics in Emily Robitschek's work include Cancer Immunotherapy and Biomarkers (2 papers), CAR-T cell therapy research (2 papers) and MicroRNA in disease regulation (1 paper). Emily Robitschek is often cited by papers focused on Cancer Immunotherapy and Biomarkers (2 papers), CAR-T cell therapy research (2 papers) and MicroRNA in disease regulation (1 paper). Emily Robitschek collaborates with scholars based in United States and Spain. Emily Robitschek's co-authors include Alvin Shi, Arnav Mehta, Arlene H. Sharpe, Chien‐Fu Hung, Benchun Miao, Eliezer M. Van Allen, Tatyana Sharova, Jiajia Chen, Jia‐Ren Lin and John H. Shin and has published in prestigious journals such as Cancer Research and Regular and Young Investigator Award Abstracts.

In The Last Decade

Emily Robitschek

2 papers receiving 2 citations

Peers

Emily Robitschek
M. Nie China
Aritri Mandal United Kingdom
Shristi Upadhyay United States
C. Gnanachandran United Kingdom
Iwona Kiecka United States
Samuel Finlay United Kingdom
D. Andrew Tucker United States
Emily Robitschek
Citations per year, relative to Emily Robitschek Emily Robitschek (= 1×) peers Timur Lankov

Countries citing papers authored by Emily Robitschek

Since Specialization
Citations

This map shows the geographic impact of Emily Robitschek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Robitschek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Robitschek more than expected).

Fields of papers citing papers by Emily Robitschek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Robitschek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Robitschek. The network helps show where Emily Robitschek may publish in the future.

Co-authorship network of co-authors of Emily Robitschek

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Robitschek. A scholar is included among the top collaborators of Emily Robitschek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Robitschek. Emily Robitschek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

3 of 3 papers shown
1.
Vokes, Natalie I., Cora A. Ricker, Emily Robitschek, et al.. (2023). Abstract 3271: Multiomic meta-analysis of differential response to PD-1 and CTLA-4 blockade in metastatic melanoma. Cancer Research. 83(7_Supplement). 3271–3271. 1 indexed citations
2.
Robitschek, Emily, Arnav Mehta, Jia‐Ren Lin, et al.. (2022). 916 Acquired resistance to immune checkpoint blockade by phenotypic plasticity of melanoma. Regular and Young Investigator Award Abstracts. A955–A955.
3.
Robitschek, Emily, et al.. (2015). Abstract 448: The role of the Nanog transcription factor in tumor immune escape. Cancer Research. 75(15_Supplement). 448–448. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026